Meta to report fourth-quarter earnings after the bell

Meta's CEO Mark Zuckerberg attends the Senate Judiciary Committee hearing on online child sexual exploitation at the U.S. Capitol in Washington, U.S., January 31, 2024. Evelyn Hockstein | ReutersMeta will report fourth-quarter earnings after the bell on Thursday.Here's what analysts surveyed by LSEG, formerly Refinitiv, are expecting:Earnings: $4.96 per shareRevenue: $39.18...

Read more...

Qualcomm (QCOM) earnings report Q1 2024

Qualcomm CEO Cristiano Amon responds to a question during a keynote conversation at CES 2024, an annual consumer electronics trade show, in Las Vegas, Nevada, on Jan. 10, 2024.Steve Marcus | ReutersQualcomm reported fiscal first-quarter results on Wednesday that topped analysts' estimates as sales of handset chips jumped 16%...

Read more...

GSK posts blowout RSV vaccine sales, raises outlook

Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. Dado Ruvic | ReutersGlaxoSmithKline on Wednesday lifted its long-term outlook following the smash-hit launch of its new RSV vaccine.The shot targeting the severe and in some cases life-threatening virus booked around £1.2 billion, or...

Read more...

Novo Nordisk hits $500 billion in market value as it flags soaring demand for Wegovy, Ozempic

Liselotte Sabroe | Afp | Getty ImagesNovo Nordisk on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular anti-obesity and diabetes drugs continued to soar.The maker of weight loss drug Wegovy and diabetes drug Ozempic reported an increase in sales of 31% in Danish kroner and 36%...

Read more...